Amarin Statistics
NASDAQ: AMRNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
12.02-0.05 (-0.41%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Amarin by the numbers
Amarin has a market capitalization of $253.9 million based on 21.12M shares outstanding. With trailing EPS of $-1.20, Amarin is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.9% below its 50-day average and 17.3% below its 200-day average.
Average daily trading volume is 66.63K shares, or about $800,845 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AMRN valuation vs. peer median
| Metric | AMRN | Peer median | Difference |
|---|---|---|---|
| Market cap | $253.90M | $249.97M | +2% |
| Avg. volume | 66.63K | 497.36K | -87% |
Peer median across 8 companies: ACIU, UPB, ZNTL, IMRX, BCYC, LFCR, VCRE, AKBA.
Valuation
- Market cap
- $253.90M
- Forward P/E
- 12.27
- EPS (TTM)
- $-1.20
- Shares outstanding
- 21.12M
Price and trading
- Previous close
- 12.07
- Open
- 11.99
- Day range
- 11.86 – 12.05
- 52-week range
- 11.83 – 20.90
- 52-week change
- -37.62%
- Beta
- —
- Volume
- 74.94K
- Average volume
- 66.63K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 253.90M
- Forward Pe
- 12.27
- Eps
- -1.20
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 20.90
- Week52 Low
- 11.83
- Avg Volume
- 66,626.00
- Shares Outstanding
- 21.12M
- Ma50
- 13.81
- Ma200
- 14.53
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -42.49%
- Pct From52w Low
- 1.61%